Filing Details
- Accession Number:
- 0001140361-17-019040
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-09 13:21:53
- Reporting Period:
- 2017-04-28
- Filing Date:
- 2017-05-09
- Accepted Time:
- 2017-05-09 13:21:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1380710 | Eric George Davis | C/O Biomarin Pharmaceutical Inc. 770 Lindaro St. San Rafael CA 94901 | Evp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-04-28 | 302 | $70.30 | 85,251 | No | 5 | A | Direct | |
| Common Stock | Acquisiton | 2017-05-05 | 2,500 | $38.59 | 87,751 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-05-05 | 2,500 | $100.34 | 85,251 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to buy Common Stock) | Disposition | 2017-05-05 | 2,500 | $0.00 | 2,500 | $38.59 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 39,844 | 2008-11-22 | 2018-05-21 | No | 4 | M | Direct |
Footnotes
- Represents shares acquired by the reporting person on April 28, 2017, pursuant to the issuer's Employee Stock Purchase Plan.
- Trade made pursuant to a 10b5-a plan executed on November 2, 2016.
- All shares were sold at the same price.
- Reflects the number of stock options outstanding after the transaction from this specific stock option grant.
Billionaire Hedge Funds
